Analyst consensus rating
Pulmonx Analyst Rating: none
Direct answer
Pulmonx's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.40.
Forecast evidence checked October 17, 2026.
Get free Pulmonx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.78
- Average price target
- $3.40
- High price target
- $5.00
- Low price target
- $2.50
- Low target gap
- +40.4%
- Target upside
- +91%
- High target gap
- +180.9%
- Target range width
- 140.4%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pulmonx?
Pulmonx has a verified none consensus. The same dataset has an average price target of $3.40.
How far are Pulmonx's low and high targets from the recorded price?
The low target implies +40.4%, while the high target implies +180.9%.
How many analysts are included in Pulmonx's consensus?
The verified consensus includes 5 analysts.
How is Pulmonx's target upside or downside calculated?
The average target of $3.40 is divided by the recorded price of $1.78, then one is subtracted to produce +91%. This does not guarantee a future return.
When was Pulmonx's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.